Company Valuation: Embla Medical hf.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 2,720 2,025 1,711 2,115 2,187 1,822 - -
Change - -25.54% -15.52% 23.63% 3.42% -16.73% - -
Enterprise Value (EV) 1 3,083 2,429 2,106 2,529 2,626 2,217 2,174 2,130
Change - -21.2% -13.31% 20.1% 3.84% -15.6% -1.93% -2%
P/E ratio 41.1x 47.6x 28.4x 30.6x 26.2x 19.5x 16.6x 14.3x
PBR 4.33x 3.26x 2.38x 2.73x 2.46x 1.86x 1.69x 1.52x
PEG - -1.5x 0.8x 1.5x 4.07x 1.4x 1x 0.9x
Capitalization / Revenue 3.78x 2.82x 2.18x 2.47x 2.36x 1.78x 1.65x 1.52x
EV / Revenue 4.29x 3.38x 2.68x 2.96x 2.83x 2.17x 1.97x 1.78x
EV / EBITDA 20.7x 19x 15.1x 14.6x 14.1x 10.6x 9.37x 8.28x
EV / EBIT 31.7x 30.8x 23.6x 22.4x 21x 15.6x 13.6x 11.9x
EV / FCF 41.7x 69.4x 40.5x 32.8x 26.3x 22.2x 18.2x 16.8x
FCF Yield 2.4% 1.44% 2.47% 3.04% 3.81% 4.51% 5.48% 5.96%
Dividend per Share 3 - - - - - - - -
Rate of return - - - - - - - -
EPS 3 1.03 0.7053 0.9656 1.164 1.239 1.41 1.649 1.919
Distribution rate - - - - - - - -
Net sales 1 718.7 718.6 785.7 854.9 928.7 1,022 1,105 1,197
EBITDA 1 149 128.2 139.3 173.3 185.9 209.8 232 257.4
EBIT 1 97.31 78.84 89.39 113.2 125.3 142.1 159.5 179.6
Net income 1 63.99 42.51 58.39 68.28 83.34 94.5 109.9 126.2
Net Debt 1 363 404 395 414 439 395.1 352.4 308.9
Reference price 3 42.30 33.55 27.45 35.60 32.50 27.45 27.45 27.45
Nbr of stocks (in thousands) 4,22,208 4,20,145 4,20,298 4,26,934 4,27,326 4,26,703 - -
Announcement Date 01/02/22 31/01/23 30/01/24 05/02/25 03/02/26 - - -
1DKK in Million2USD in Million3DKK
Estimates

P/E ratio, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
19.46x2.17x10.57x-.--% 180.94Cr
31.39x5.36x17.96x1.08% 1.89TCr
20.7x3.42x12.56x2.25% 1.56TCr
25.95x2.74x13.02x3.42% 464.52Cr
19.12x2.47x9.58x1.96% 404.19Cr
49.82x3.05x24.26x0.92% 154.86Cr
19.49x4.19x12.1x1.03% 118.31Cr
-17.83x - - - 37Cr
Average 21.01x 3.34x 14.29x 1.52% 600.81Cr
Weighted average by Cap. 25.83x 4.00x 14.78x 1.72%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. EMBLA Stock
  4. Valuation Embla Medical hf.